Clinical research is critical to medical progress, providing the data necessary to develop new treatments, improve outcomes, and offer hope to patients. Nowhere is this hope more urgently needed than ...
Australian researchers say they have identified a new, highly targeted way to attack myelofibrosis, a rare and serious blood cancer, raising hopes for more effective treatments that go beyond symptom ...
GARD provides access to information and resources that are current, reliable, and clear. Using the support GARD offers can help ensure you are getting the best possible care for your rare disease. Here, learn what kind of information and resources GARD offers.
Diseases Browse by Disease Explore GARD's list of rare diseases. Filter by category or search by disease name, acronym, or synonym. Rare diseases found on GARD should not be used as policy statements of NCATS or the NIH.
What should you know about GARD? GARD is a program of the National Institutes of Health that provides free access to reliable, easy-to-understand information about genetic and rare diseases.
We invite patients, family members, caregivers, and others seeking information about rare diseases to contact GARD by leaving us a detailed voice message or through our contact form. Our Information Specialists provide personalized responses that are easy to understand, free of charge, and confidential.
Please note: GARD provides organizations for informational purposes only and not as an endorsement of their services. Contact a GARD Information Specialist for more information on organizations that may be dedicated to this disease. Please contact an organization directly if you have questions about the information or resources it provides.
Comuníquese con GARD Los Especialistas en Información de GARD brindan ayuda individualizada para conectarle con información y recursos. Nuestros Especialistas en Información pueden ayudarle: Encontrar o comprender información sobre una enfermedad rara. Navegar por la información sobre cómo obtener un diagnóstico de una enfermedad rara.
MarketWatch: myTomorrows and Rare Disease Research Partner to Improve Access to Rare Disease Clinical Trials
myTomorrows and Rare Disease Research Partner to Improve Access to Rare Disease Clinical Trials The collaboration is designed to increase trial visibility, support more structured referrals from ...
myTomorrows and Rare Disease Research Partner to Improve Access to Rare Disease Clinical Trials
ucdavis.edu: Where's Our CRISPR? New Treatments Promise Hope for Rare Diseases, But Wait May be Long
CRISPR gene editing has now been used to treat a genetic defect in a child, giving hope to parents of children with rare inherited diseases. While hopes are high, clear communication about the ...
Where's Our CRISPR? New Treatments Promise Hope for Rare Diseases, But Wait May be Long
If you’re faced with a serious disease, you better hope it’s not a rare one. After an often tortuous path to diagnosis, people with rare diseases are likely to find that good treatment options don’t ...
Construction of low volume seal roads We build low-volume seal roads designed to handle lighter traffic loads efficiently. Our approach combines cost-effectiveness with durability, providing long-lasting roads suitable for rural and less trafficked areas.
Despite decades of research and billions in spending, some of the most aggressive cancers remain devastatingly lethal. Glioblastoma, the most frequently diagnosed malignant brain tumor in adults, ...
Scientific breakthroughs and cutting-edge technologies are transforming the diagnosis and treatment of rare diseases, offering new hope to millions of patients and families. National Institutes of ...
Researchers from Children's Hospital of Philadelphia (CHOP) developed a new RNA sequencing strategy that can reveal how genetic variants disrupt gene function and improve the diagnosis of rare ...
Access 160+ million publication pages and connect with 25+ million researchers. Join for free and gain visibility by uploading your research.
Find the research you need | With 160+ million publication pages, 1+ million questions, and 25+ million researchers, this is where everyone can access science
Pew Research Center is a nonpartisan, nonadvocacy fact tank that informs the public about the issues, attitudes and trends shaping the world.
Login to ResearchGate to access millions of publications and connect with researchers worldwide.
Media & Society Medicine & Health Methodological Research Middle Class Migration Issues Military & Veterans Military & Veterans Millennials Millennials & Other Age Groups Misinformation Misinformation Online Mobile More Leaders More Platforms & Services More Racial & Ethnic Groups Motherhood & Fatherhood Music Muslim Americans Muslims Around ...
This research article explores the essence, functions, and process of research, with a specific focus on scientific research. In addition, it delves into the characteristics of scientific research ...
About this research This Pew Research Center analysis examines Americans’ views of the U.S. military action against Iran, which began in February 2026. Pew Research Center conducts research to help the public, media and decision-makers understand important topics. We have studied Americans’ views of politics and major policy issues, including the use of U.S. military force, for decades. We ...
The number of unauthorized immigrants in the United States reached an all-time high of 14 million in 2023 after two consecutive years of record growth, according to a new Pew Research Center estimate. The increase of 3.5 million in two years is the biggest on record.
Pew Research Center conducted this study to better understand teens’ use of digital devices, social media and other online platforms. The Center conducted an online survey of 1,391 U.S. teens from Sept. 18 to Oct. 10, 2024, through Ipsos.
Morningstar: As Rare Disease Drug Approvals Accelerate, PANTHERx® Releases Research on Strengthening Care Coordination
PANTHERx Rare: A Purpose-Built Model Designed for Rare Diseases As therapies become more specialized and care journeys more complex, the research underscores the need for approaches that reduce ...
As Rare Disease Drug Approvals Accelerate, PANTHERx® Releases Research on Strengthening Care Coordination
As the grandfather of a girl with a rare disease, I’ve learned that for families like ours, hope often comes not as a cure, but as a clinical trial: carefully designed but inevitably exclusive. My ...
The Scientist: What Rare Disease Research Teaches Us About the Future of Precision Medicine
For decades, rare disease research was treated as noble but incidental, peripheral to the pharmaceutical industry’s market-driven priorities. While blockbuster drug discovery focused on the "average ...